Biochemistry Terms Starting With B
Biochemistry Glossary: B
Beta Oxidation
/ BAY-ta ok-si-DAY-shun / · Greek beta (second letter) + Latin oxidatus (combined with oxygen)
Beta oxidation is the metabolic pathway that breaks down fatty acids into acetyl-CoA molecules by systematically removing two-carbon units from the fatty acid chain.
This catabolic process occurs primarily in the mitochondrial matrix and generates significant amounts of ATP for cellular energy. Each cycle produces one acetyl-CoA, one FADH2, and one NADH molecule. A 16-carbon palmitic acid molecule yields 8 acetyl-CoA units through 7 cycles, ultimately generating approximately 129 ATP molecules when fully oxidized.
Before entering the mitochondria, fatty acids must first be activated to acyl-CoA and transported across the inner mitochondrial membrane by the carnitine shuttle system.
The human heart derives about 70% of its energy from beta oxidation of fatty acids, making it the most fat-dependent organ in the body.
Mitochondria Functions →Beta oxidation takes place in the cytoplasm. This fatty acid breakdown process occurs in the mitochondrial matrix, where the acetyl-CoA it produces feeds directly into the citric acid cycle.
During prolonged fasting, muscle cells in humans increase beta oxidation of stored fatty acids to preserve glucose for brain function. A single gram of fat yields more than twice the ATP of a gram of glucose, making fatty acids the preferred fuel for sustained low-intensity activity.
Binding Affinity
/ BIND-ing ?-FIN-i-tee / · Latin bindere (to tie) + affinis (related, connected)
Binding affinity is the strength of attraction between two molecules, such as a protein and its ligand, measured by how tightly they bind together.
Scientists measure binding affinity using the dissociation constant (Kd), where lower values indicate stronger binding. Hemoglobin demonstrates high binding affinity for oxygen with a Kd of approximately 2.8 torr, enabling efficient oxygen transport in blood. Drug development relies heavily on binding affinity measurements, as pharmaceutical compounds must bind strongly enough to their target proteins to produce therapeutic effects.
Structural complementarity between the binding site and the ligand, including shape, charge distribution, and hydrophobic character, determines the magnitude of the Kd.
The binding affinity between biotin and avidin is so strong (Kd = 10^-15 M) that it represents one of the strongest non-covalent interactions known in nature.
Are Enzymes Proteins? →High binding affinity always equals better biological function. Extremely tight binding can prevent necessary molecular release, and many signaling interactions require rapid dissociation to reset the system.
The drug imatinib binds to the BCR-ABL kinase in chronic myeloid leukemia cells with a Kd in the nanomolar range, a tight enough interaction to block the aberrant signaling that drives tumor growth while still permitting dissociation during normal cellular cycling.
Biocatalyst
/ BY-oh-cat-a-list / · Greek bios (life) + katalysis (dissolution)
Biocatalyst biocatalyst is a biological molecule that accelerates chemical reactions by lowering the activation energy required for the reaction to proceed.
Enzymes represent the most common type of biocatalyst in living systems, though catalytic RNA molecules called ribozymes also qualify. The enzyme catalase, found in human liver cells, breaks down 40 million molecules of hydrogen peroxide per second into water and oxygen. Industrial biotechnology harnesses biocatalysts such as lipases and proteases to manufacture pharmaceuticals, food additives, and biodegradable plastics under milder conditions than traditional chemical processes.
Unlike inorganic catalysts, most biocatalysts are highly specific, recognizing only one substrate or a narrow group of structurally related substrates.
The ribosome, the molecular machine that synthesizes every protein in a cell, is itself a ribozyme: the catalytic activity resides in its ribosomal RNA, not its protein components, a finding that earned Thomas Cech and Sidney Altman the 1989 Nobel Prize in Chemistry.
Biocatalysts get consumed during the reactions they speed up. A biocatalyst emerges from each reaction chemically unchanged and can catalyze the same reaction repeatedly until it is degraded by the cell.
Pepsin catalyzes reactions a biocatalyst in the human stomach, breaking down proteins into smaller peptides at the acidic pH of approximately 2 found in gastric juice. A single pepsin molecule can cleave thousands of peptide bonds before it is denatured or degraded.
Biochemical Pathway
/?ba?-o?-KEM-i-k?l PATH-we?/ · Greek bios (life) + khemeia (alchemy) + Old English paeth (track)
Biochemical Pathway biochemical pathway is a series of chemical reactions occurring within a cell where each step is catalyzed by a specific enzyme and the product of one reaction becomes the substrate for the next.
These interconnected reactions break down nutrients, synthesize molecules, and maintain cellular functions. Glycolysis, for example, converts one molecule of glucose into two molecules of pyruvate through a sequence of ten enzyme-catalyzed steps, releasing energy that cells capture as ATP. Each pathway operates under precise regulation, with feedback mechanisms that control the rate and direction of metabolic flow based on cellular needs.
When the end product of a pathway accumulates, it often inhibits an early enzyme in that same pathway, a control strategy called feedback inhibition that prevents wasteful overproduction.
The human body contains over 3,000 different biochemical pathways, with some reactions occurring millions of times per second in a single cell.
Biochemical pathways are separate routes working independently inside cells. They connect into larger networks, share intermediate molecules, and influence each other through regulation, so changes in one pathway can shift flux through several others simultaneously.
Escherichia coli uses the pentose phosphate pathway to generate NADPH and ribose-5-phosphate for nucleotide synthesis. When grown on glucose-rich media at 37°C, E. coli directs roughly 10-15% of its glucose flux through this pathway to meet biosynthetic demand.
Biomolecule
/BI-o-mol-e-cule/ · Greek bios (life) + Latin molecula (small mass)
Biomolecule is any molecule produced by a living organism that contains carbon as its structural backbone.
These carbon-based compounds include four major classes: carbohydrates, proteins, lipids, and nucleic acids. Each class carries out distinct functions within cells, from providing energy storage to encoding genetic information. Glucose, with its 6 carbon atoms, supplies the primary energy currency for most organisms, while a single human DNA molecule can contain over 3 billion nucleotide units encoding hereditary information.
Lipids such as phospholipids form the bilayer membranes that define cell boundaries, demonstrating how structural diversity among biomolecules underpins the full range of cellular architecture.
Collagen, the most abundant protein in the human body, accounts for roughly 30% of total body protein and forms the structural scaffold of skin, tendons, and bone. Its triple-helix structure depends on the amino acid hydroxyproline, which requires vitamin C for its synthesis, explaining why vitamin C deficiency causes the connective tissue breakdown seen in scurvy.
Any carbon-containing molecule qualifies as a biomolecule. Synthetic carbon compounds such as polyethylene and polystyrene are not biomolecules because living organisms do not produce them through biological processes.
Hemoglobin in red blood cells transports oxygen throughout the human circulatory system. Each hemoglobin molecule carries four heme groups, and a single red blood cell contains approximately 270 million hemoglobin molecules, giving it the capacity to carry about one billion oxygen molecules at once.
Branched-Chain Amino Acid
/ BRANCHED-chayn uh-MEE-noh AS-id / · English branched (having divisions) + chain (connected series) + Greek amino (containing nitrogen) + Latin acidus (sour)
Branched-chain amino acids are three essential amino acids, leucine, isoleucine, and valine, that carry branched aliphatic side chains and cannot be synthesized by the human body.
These three amino acids together account for approximately 35% of all muscle protein in humans. Unlike most other amino acids that undergo catabolism in the liver, branched-chain amino acids are primarily metabolized in skeletal muscle tissue, where the enzyme branched-chain aminotransferase is highly expressed. During prolonged aerobic exercise, skeletal muscle can oxidize leucine directly for fuel, contributing up to 10% of total energy expenditure when glycogen stores run low.
Maple syrup urine disease, caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex, leads to toxic accumulation of leucine, isoleucine, and valine in blood and urine. Without dietary restriction, neurological damage can begin within days of birth.
Branched-chain amino acids are broken down primarily in the liver like most other amino acids. They are catabolized mainly in skeletal muscle, where branched-chain aminotransferase activity is far higher than in hepatic tissue.
Salmon (Oncorhynchus spp.) contains high concentrations of leucine, isoleucine, and valine that support muscle protein synthesis during the energetically demanding upstream spawning migration. Leucine alone can constitute roughly 8% of the total amino acid content in salmon muscle tissue.
Buffer
/ BUF-fer / · French buffet (to strike, cushion)
Buffer is a solution that resists changes in pH when small amounts of acid or base are added.
Biological buffers typically consist of a weak acid and its conjugate base, working together to maintain stable pH levels in cells and body fluids. The bicarbonate buffer system in human blood maintains pH at 7.4, with a clinically acceptable range of 7.35 to 7.45. Deviations outside this range, even by 0.1 pH units, can impair enzyme function and disrupt oxygen delivery.
The Henderson-Hasselbalch equation describes buffer behavior mathematically, relating the solution pH to the pKa of the weak acid and the ratio of conjugate base to weak acid concentrations.
The human body contains multiple buffer systems, with phosphate buffers being most effective inside cells where pH is around 7.2.
Buffers keep pH completely unchanged when acid or base is added. Buffers only reduce the magnitude of pH shifts, and their resistance weakens as their buffering capacity is consumed by repeated additions of acid or base.
The bicarbonate buffer system in human blood prevents dangerous pH fluctuations that could disrupt enzyme function and cellular processes. When a patient hyperventilates and exhales excess CO2, blood pH can rise above 7.45, a condition called respiratory alkalosis, illustrating that the buffer system can be overwhelmed by physiological changes.
Buffer Capacity
/BUF-fer ca-PAS-i-ty/ · French buffer (to strike, cushion) + Latin capacitas (ability to hold)
Buffer capacity is the quantitative measure of a buffer solution's ability to resist pH changes when a given amount of acid or base is added.
Buffer capacity depends on both the total concentration of the buffering components and the ratio of weak acid to conjugate base. Human blood maintains a bicarbonate buffer capacity of approximately 40 to 50 mmol/L, keeping blood pH within the narrow range of 7.35 to 7.45 despite continuous metabolic acid production. Maximum buffer capacity occurs when the concentrations of weak acid and conjugate base are equal, at a pH equal to the pKa of the buffering pair.
Diluting a buffer solution lowers its capacity even if the pH remains unchanged, because fewer moles of buffering species are available to absorb incoming acid or base.
The bicarbonate buffer system in human blood can neutralize about 15 times more acid than base due to its asymmetric composition and open system design.
Buffer strength stays constant regardless of concentration. The actual buffering power depends directly on how many moles of weak acid and conjugate base are present, so a more concentrated buffer resists pH changes far more effectively than a dilute one at the same pH.
The phosphate buffer system in human red blood cells maintains intracellular pH near 7.2 despite the continuous production of lactic acid during anaerobic glycolysis. At the typical intracellular phosphate concentration of roughly 1 to 2 mmol/L, this system provides a measurable but limited capacity compared to the bicarbonate system in plasma.
